BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37324130)

  • 1. Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy.
    Xiang J; Ma L; Tong J; Zuo N; Hu W; Luo Y; Liu J; Liang T; Ren Q; Liu Q
    Front Med (Lausanne); 2023; 10():1199881. PubMed ID: 37324130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.
    Xiang J; Ma L; Gu Z; Jin H; Zhai H; Tong J; Liang T; Li J; Ren Q; Liu Q
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 6. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
    BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
    Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
    Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar T/N ratio between
    Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
    Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model.
    Hanaoka K; Watabe T; Naka S; Kanai Y; Ikeda H; Horitsugi G; Kato H; Isohashi K; Shimosegawa E; Hatazawa J
    EJNMMI Res; 2014 Dec; 4(1):70. PubMed ID: 25621196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of boron in human malignant glioma cells in vitro is cell type dependent.
    Dahlström M; Capala J; Lindström P; Wasteson A; Lindström A
    J Neurooncol; 2004 Jul; 68(3):199-205. PubMed ID: 15332322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomic emission method for total boron in blood during neutron-capture therapy.
    Laakso J; Kulvik M; Ruokonen I; Vähätalo J; Zilliacus R; Färkkilä M; Kallio M
    Clin Chem; 2001 Oct; 47(10):1796-803. PubMed ID: 11568089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy.
    Doi A; Kawabata S; Iida K; Yokoyama K; Kajimoto Y; Kuroiwa T; Shirakawa T; Kirihata M; Kasaoka S; Maruyama K; Kumada H; Sakurai Y; Masunaga S; Ono K; Miyatake S
    J Neurooncol; 2008 May; 87(3):287-94. PubMed ID: 18219552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
    Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
    Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.